Residency · Durham, NC
Sponsored by Duke University Hospital
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion.
The New England journal of medicine · 2025 · 203 citations · Shahid Nimjee
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
The New England journal of medicine · 2023 · 643 citations · Katherine Peters
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 714 citations · Erik Sulman
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 468 citations · Daniel Barboriak
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature · 2022 · 697 citations · Gerald Grant
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Nature · 2025 · 172 citations · Gerald Grant
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Neuro-oncology · 2023 · 466 citations · Mustafa Khasraw
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types.
Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 855 citations · Mustafa Khasraw